WBP2 and breast cancer: We found a higher expression of WBP2 in breast cells than in normal breast epithelial cells, especially in highly aggressive breast cancer cells (MDA-MB-231 and SKBR3) or doxorubicin-resistant MCF7/ADR cells (Fig. 1a).